verified SJR 2,756 · Q1 • database Scopus / SJR & Web of Science indexed

Germany · Springer Science and Busines...

workspace_premium Q1 — Molecular Biology lock Subscription

EMBO Reports

EMBO Reports is a journal indexed in SJR in Molecular Biology and Genetics with an H index of 219. It has a price of 4700 €. It has an SJR impact factor of 2,756 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,756.

EMBO Reports focuses its scope in these topics and keywords: cell, stem, biology, therapy, synthetic, development, amphipathic, computer, expectations, function, ...

ISSN: 1469-221X

Publisher: Springer Science and Business Media Deutschland GmbH

Category: Molecular Biology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

2,756 Q1

H-index 219

Acceptance rate pie_chart

20% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

4.700 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

2,756

H-index

219

Docs (year)

308

Docs 3y

970

Total refs

18286

Cites 3y

5019

Citable 3y

800

Cites/Doc 2y

4.73

Ref/Doc

59.37

Immediate OA

4700 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Branched-chain ketoacids secreted by glioblastoma cells via

Zc3h10 is a novel mitochondrial regulator

Dcr2 targets Ire1 and downregulates the unfolded protein response in

Data donation after death

Cyclic AMP signalling in

CRISPR

Cripto shapes macrophage plasticity and restricts EndMT in injured and diseased skeletal muscle

Chemokines and galectins form heterodimers to modulate inflammation

Chemoattractant-induced Ras activation during

Chemerin15 inhibits neutrophil-mediated vascular inflammation and myocardial ischemia-reperfusion injury through ChemR23

Cdc48 and Ufd3, new partners of the ubiquitin protease Ubp3, are required for ribophagy

Calcineurin: a central controller of signalling in eukaryotes

SHOW MORE ARTICLES

Brown adipocyte glucose metabolism: a heated subject

A one-carbon path for fixing

Architecture of the yeast Elongator complex

Apoptosis and disease: a life or death decision

Antagonistic regulation of EMT by TIF1 gamma and Smad4 in mammary epithelial cells

An estimate of large-scale sequencing accuracy

Allosteric auto-inhibition and activation of the Nedd4 family E3 ligase Itch

Adherens junction remodelling during mitotic rounding of pseudostratified epithelial cells

ADAR

Acetylcholine receptor channel subtype directs the innervation pattern of skeletal muscle

Accelerating drug discovery

A role for chemokine receptor transactivation in growth factor signaling

FAQs

EMBO Reports has an SJR of 2,756 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 4700 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for EMBO Reports is 20%.

EMBO Reports

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of EMBO Reports?

What is the APC / publication cost?

What is the acceptance rate?